Recombinant Antibody Market - Global Outlook and Forecast 2022-2028

January 2022 | 69 pages | ID: RF69EFEE4B86EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Recombinant Antibody in Global, including the following market information:

Global Recombinant Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Recombinant Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chimeric Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Antibody include Abnova, Medix Biochemica, GE Healthcare, SinoBiological and Bioventix, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Antibody Market Segment Percentages, by Type, 2021 (%)

• Chimeric Antibody
• Humanized Antibody
• Full Human Antibody
• Single Chain Antibody
• Bispecific Antibody

Global Recombinant Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Antibody Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Scientific Research
• Others

Global Recombinant Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Recombinant Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Recombinant Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abnova
• Medix Biochemica
• GE Healthcare
• SinoBiological
• Bioventix

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT ANTIBODY OVERALL MARKET SIZE

2.1 Global Recombinant Antibody Market Size: 2021 VS 2028
2.2 Global Recombinant Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Recombinant Antibody Players in Global Market
3.2 Top Global Recombinant Antibody Companies Ranked by Revenue
3.3 Global Recombinant Antibody Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies Recombinant Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Antibody Players in Global Market
  3.6.1 List of Global Tier 1 Recombinant Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 Recombinant Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Recombinant Antibody Market Size Markets, 2021 & 2028
  4.1.2 Chimeric Antibody
  4.1.3 Humanized Antibody
  4.1.4 Full Human Antibody
  4.1.5 Single Chain Antibody
  4.1.6 Bispecific Antibody
4.2 By Type - Global Recombinant Antibody Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Antibody Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant Antibody Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Antibody Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Scientific Research
  5.1.4 Others
5.2 By Application - Global Recombinant Antibody Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Antibody Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant Antibody Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Antibody Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Antibody Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Antibody Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant Antibody Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Recombinant Antibody Revenue, 2017-2028
  6.3.2 US Recombinant Antibody Market Size, 2017-2028
  6.3.3 Canada Recombinant Antibody Market Size, 2017-2028
  6.3.4 Mexico Recombinant Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Recombinant Antibody Revenue, 2017-2028
  6.4.2 Germany Recombinant Antibody Market Size, 2017-2028
  6.4.3 France Recombinant Antibody Market Size, 2017-2028
  6.4.4 U.K. Recombinant Antibody Market Size, 2017-2028
  6.4.5 Italy Recombinant Antibody Market Size, 2017-2028
  6.4.6 Russia Recombinant Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries Recombinant Antibody Market Size, 2017-2028
  6.4.8 Benelux Recombinant Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Recombinant Antibody Revenue, 2017-2028
  6.5.2 China Recombinant Antibody Market Size, 2017-2028
  6.5.3 Japan Recombinant Antibody Market Size, 2017-2028
  6.5.4 South Korea Recombinant Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia Recombinant Antibody Market Size, 2017-2028
  6.5.6 India Recombinant Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Recombinant Antibody Revenue, 2017-2028
  6.6.2 Brazil Recombinant Antibody Market Size, 2017-2028
  6.6.3 Argentina Recombinant Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Recombinant Antibody Revenue, 2017-2028
  6.7.2 Turkey Recombinant Antibody Market Size, 2017-2028
  6.7.3 Israel Recombinant Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia Recombinant Antibody Market Size, 2017-2028
  6.7.5 UAE Recombinant Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abnova
  7.1.1 Abnova Corporate Summary
  7.1.2 Abnova Business Overview
  7.1.3 Abnova Recombinant Antibody Major Product Offerings
  7.1.4 Abnova Recombinant Antibody Revenue in Global Market (2017-2022)
  7.1.5 Abnova Key News
7.2 Medix Biochemica
  7.2.1 Medix Biochemica Corporate Summary
  7.2.2 Medix Biochemica Business Overview
  7.2.3 Medix Biochemica Recombinant Antibody Major Product Offerings
  7.2.4 Medix Biochemica Recombinant Antibody Revenue in Global Market (2017-2022)
  7.2.5 Medix Biochemica Key News
7.3 GE Healthcare
  7.3.1 GE Healthcare Corporate Summary
  7.3.2 GE Healthcare Business Overview
  7.3.3 GE Healthcare Recombinant Antibody Major Product Offerings
  7.3.4 GE Healthcare Recombinant Antibody Revenue in Global Market (2017-2022)
  7.3.5 GE Healthcare Key News
7.4 SinoBiological
  7.4.1 SinoBiological Corporate Summary
  7.4.2 SinoBiological Business Overview
  7.4.3 SinoBiological Recombinant Antibody Major Product Offerings
  7.4.4 SinoBiological Recombinant Antibody Revenue in Global Market (2017-2022)
  7.4.5 SinoBiological Key News
7.5 Bioventix
  7.5.1 Bioventix Corporate Summary
  7.5.2 Bioventix Business Overview
  7.5.3 Bioventix Recombinant Antibody Major Product Offerings
  7.5.4 Bioventix Recombinant Antibody Revenue in Global Market (2017-2022)
  7.5.5 Bioventix Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Recombinant Antibody Market Opportunities & Trends in Global Market
Table 2. Recombinant Antibody Market Drivers in Global Market
Table 3. Recombinant Antibody Market Restraints in Global Market
Table 4. Key Players of Recombinant Antibody in Global Market
Table 5. Top Recombinant Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Recombinant Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Recombinant Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies Recombinant Antibody Product Type
Table 9. List of Global Tier 1 Recombinant Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Recombinant Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Recombinant Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Recombinant Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Recombinant Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Recombinant Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Recombinant Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Recombinant Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Recombinant Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Recombinant Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Recombinant Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Recombinant Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Recombinant Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Recombinant Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Recombinant Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Recombinant Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Recombinant Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Recombinant Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Recombinant Antibody Revenue, (US$, Mn), 2023-2028
Table 30. Abnova Corporate Summary
Table 31. Abnova Recombinant Antibody Product Offerings
Table 32. Abnova Recombinant Antibody Revenue (US$, Mn), (2017-2022)
Table 33. Medix Biochemica Corporate Summary
Table 34. Medix Biochemica Recombinant Antibody Product Offerings
Table 35. Medix Biochemica Recombinant Antibody Revenue (US$, Mn), (2017-2022)
Table 36. GE Healthcare Corporate Summary
Table 37. GE Healthcare Recombinant Antibody Product Offerings
Table 38. GE Healthcare Recombinant Antibody Revenue (US$, Mn), (2017-2022)
Table 39. SinoBiological Corporate Summary
Table 40. SinoBiological Recombinant Antibody Product Offerings
Table 41. SinoBiological Recombinant Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Bioventix Corporate Summary
Table 43. Bioventix Recombinant Antibody Product Offerings
Table 44. Bioventix Recombinant Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Antibody Segment by Type in 2021
Figure 2. Recombinant Antibody Segment by Application in 2021
Figure 3. Global Recombinant Antibody Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Recombinant Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Antibody Revenue in 2021
Figure 8. By Type - Global Recombinant Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global Recombinant Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global Recombinant Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America Recombinant Antibody Revenue Market Share, 2017-2028
Figure 12. US Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Recombinant Antibody Revenue Market Share, 2017-2028
Figure 16. Germany Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Recombinant Antibody Revenue Market Share, 2017-2028
Figure 24. China Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Recombinant Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Recombinant Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Recombinant Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. Abnova Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Medix Biochemica Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GE Healthcare Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. SinoBiological Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bioventix Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)